"The goal of this guideline is to improve the quality of care and treatment outcomes for patients with borderline personality disorder (BPD) as defined in Section II of the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, Text Revision. Since publication of the last American Psychiatric Association (APA) practice guideline, there have been many studies on psychotherapies for individuals with BPD as well as some studies on pharmacotherapies. Despite this, there are still misconceptions about BPD and substantial gaps in the availability of evidence-based treatments for individuals with BPD. This practice guideline aims to help clinicians improve the care and well-being of their patients by reviewing current evidence and providing evidence-based statements that are intended to enhance knowledge and optimize treatment of BPD"--
